|
Volumn 157, Issue 9, 2000, Pages 1445-1452
|
Gender differences in treatment response to sertraline versus imipramine in chronic depression
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
IMIPRAMINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG RESPONSE;
DRUG TOLERABILITY;
FEMALE;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MENOPAUSE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEX DIFFERENCE;
XEROSTOMIA;
ADULT;
AGED;
AMBULATORY CARE;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
CHRONIC DISEASE;
DEPRESSIVE DISORDER;
DOUBLE-BLIND METHOD;
DYSTHYMIC DISORDER;
ESTROGENS;
FEMALE;
HUMANS;
IMIPRAMINE;
MALE;
MIDDLE AGED;
PATIENT DROPOUTS;
PLACEBOS;
PREMENOPAUSE;
PSYCHIATRIC STATUS RATING SCALES;
SEROTONIN UPTAKE INHIBITORS;
SERTRALINE;
SEVERITY OF ILLNESS INDEX;
SEX FACTORS;
TREATMENT OUTCOME;
|
EID: 0033850079
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.157.9.1445 Document Type: Article |
Times cited : (600)
|
References (33)
|